QuadraMed Corporation Market Share Analysis

Publisher Name :
Date: 12-Dec-2012
No. of pages: 45

QuadraMed Corporation Market Share Analysis

Summary

GlobalData’s new report, “QuadraMed Corporation Market Share Analysis” provides in-depth information on QuadraMed Corporation.’s market position in the clinical IT systems market. The report also provides data and information on the overall competitive landscape within the clinical IT systems market. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global company shares (in Revenues) information for the clinical IT systems market.
- QuadraMed Corporation.’s company shares (in Revenues) information for all the key countries the company has presence in – Canada and United States.
- QuadraMed Corporation.’s company shares (in Revenues) information for the clinical IT systems market.
- All the key data-points are for 2011 and cover all the key region – North America.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, QuadraMed Corporation.’s operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to QuadraMed Corporation.’s market positions.

QuadraMed Corporation Market Share Analysis

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
3 Definitions of Markets/Categories Covered 7
3.1 Healthcare IT 7
3.1.1 Clinical IT Systems 7
4 Company Snapshot 8
4.1 Key Information 8
4.2 Company Overview 8
4.3 SWOT Snapshot 8
4.4 Business Overview 9
4.5 Major Products and Services 10
4.5.1 Overview 10
5 History 11
6 SWOT Analysis 13
6.1 Overview 13
6.2 QuadraMed Corporation Strengths 13
6.2.1 Industry Recognitions 13
6.2.2 Exhaustive Suite of Consulting Services 14
6.2.3 Extensive Product Range 14
6.3 QuadraMed Corporation Weaknesses 14
6.3.1 Involvement in Legal Proceedings 14
6.4 QuadraMed Corporation Opportunities 15
6.4.1 Growth Prospects: Healthcare IT 15
6.4.2 New Business Contracts 15
6.4.3 Strategic Acquisition 15
6.5 QuadraMed Corporation Threats 16
6.5.1 Government Regulations 16
6.5.2 Competitive Landscape 16
6.5.3 Rapid Technological Advancements 16
7 Competitors 17
8 Competitive Landscape 19
8.1 Healthcare IT (Clinical IT Systems), Global, Market Share (%), 2011 19
8.2 QuadraMed Corporation, Healthcare IT (Clinical IT Systems), by Region, Market Share (2011) 21
8.3 QuadraMed Corporation, Healthcare IT (Clinical IT Systems), by Country, Market Share (2011) 22
9 Key Employees 23
10 Key Employee Biographies 24
11 Company Statement 25
12 Locations And Subsidiaries 26
12.1 Head Office 26
13 Financial Deals Landscape 27
13.1 QuadraMed Corporation, Deals Volume Summary, 2006 to YTD 2012 27
14 QuadraMed Corporation Detailed Deal Summary 29
14.1 Asset Purchase 29
14.1.1 QuadraMed Acquires Healthcare Solutions Business From NCR 29
14.2 Private Equity 31
14.2.1 Francisco Partners Completes Acquisition Of Quadramed 31
14.3 Asset Transactions 33
14.3.1 Nuance Communications To Acquire Quantim, Health Information Management Business Of QuadraMed 33
15 Recent Developments 35
15.1 Strategy And Business Planning 35
15.1.1 Aug 16, 2010: QuadraMed Partners With CPMRC To Provide Evidence-Based Clinical Content Within Their Healthcare IT Solutions 35
15.2 Corporate Communications 36
15.2.1 Jan 05, 2010: QuadraMed Appoints Thomas Dunn As Senior Vice President Of Sales And Marketing 36
15.2.2 Sep 01, 2009: QuadraMed Appoints Bonnie Cassidy As Vice President, HIM Consulting Services 36
15.2.3 Jul 27, 2009: QuadraMed Appoint Duncan James As CEO 37
15.3 Product News 37
15.3.1 Oct 26, 2009: QuadraMed CPR Receives License From Four Organizations 37
15.3.2 Jul 07, 2008: QuadraMed Announces General Availability Of Enhanced Version Of QCPR 38
15.4 Other Significant Developments 38
15.4.1 May 11, 2011: QuadraMed Renews Contract With NYCHHC For EHR Upgrade And Support 38
15.4.2 Dec 20, 2010: Texas Organization Of Rural & Community Hospitals Foundation Prepares For ICD-10 Transition With QuadraMed's Products And Services 39
16 Appendix 40
16.1 Research Methodology 41
16.2 Secondary Research 41
16.3 Primary Research 42
16.4 Models 42
16.5 Forecasts 42
16.6 Expert Panels 43
16.7 GlobalData Consulting 43
16.8 Currency Conversion 44
16.9 Contact Us 45
16.10 Disclaimer 45

1.1 List of Tables
Table 1: QuadraMed Corporation, Key Information, 2011 8
Table 2: QuadraMed Corporation, SWOT Analysis, 2011 13
Table 3: Healthcare IT (Clinical IT Systems), Global, Company Share by Revenue ($m), 2011 20
Table 4: QuadraMed Corporation, Healthcare IT (Clinical IT Systems), by Region, Revenue ($m) and Market Share (%), 2011 21
Table 5: QuadraMed Corporation, Healthcare IT (Clinical IT Systems), by Country, Revenue ($m) and Market Share (%), 2011 22
Table 6: QuadraMed Corporation, Key Employees 23
Table 7: QuadraMed Corporation, Deals Volume Summary, 2006 to YTD 2012 27
Table 8: QuadraMed Corporation, Deals Summary, 2006 to YTD 2012 28
Table 9: QuadraMed Acquires Healthcare Solutions Business From NCR 29
Table 10: Francisco Partners Completes Acquisition Of Quadramed 31
Table 11: Nuance Communications To Acquire Quantim, Health Information Management Business Of QuadraMed 33
Table 12: USD to Local Currency, Average Exchange Rate, 2011 44

1.2 List of Figures
Figure 1: Healthcare IT (Clinical IT Systems), Global, Market Share (%), 2011 19
Figure 2: QuadraMed Corporation, Healthcare IT (Clinical IT Systems), by Country, Market Share (%), 2011 22
Figure 3: QuadraMed Corporation, Deals Volume Summary, 2006 to YTD 2012 27
  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 – New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options
    Published: 29-Oct-2014        Price: US $4995 Onwards        
    GBI Research, a leading business intelligence provider, has released its latest research report: “Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options”, which provides in-depth insight into the indication. It provides estimates of market size for 2013 along with forecasts until 2020 for the eight major developed markets, which comprises the US, UK, France, Germany, Italy, Spain, Japan......
  • Cell Expansion Market by Product (Reagent, Media, Serum, Bioreactors, Centrifuge), Cell Type (human, animal), Application (Stem Cell Research, Regenerative Medicine, Clinical Diagnostics), End User (Hospital, Biotechnology, Cell Bank) – Forecast to 2019
    Published: 29-Oct-2014        Price: US $4650 Onwards        Pages: 224
    The global cell expansion market is expected to reach $14.8 billion by 2019 from $6.0 billion in 2014, growing at a CAGR of 19.7% from 2014 to 2019. The global cell expansion market is categorized on the basis of product, cell type, application, end user, and geography. The human cell expansion segment is expected to register the highest growth rate in the cell expansion market, by cell type, during the forecast period. Its favorable growth is attributed to increasing focus on human stem cell re......
  • Aortic Stent Grafts – Current and Future Players
    Published: 29-Oct-2014        Price: US $3500 Onwards        Pages: 106
    Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient’s native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated r......
  • Identifying and Commercializing First-in-Class Innovation in Non-Small-Cell Lung Carcinoma
    Published: 29-Oct-2014        Price: US $6995 Onwards        
    Large Degree of Innovation in NSCLC Pipeline The NSCLC pipeline currently has 389 products in active development across all stages, but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market comprises primarily ineffective chemotherapies that target tubulin or DNA replication, the pipeline shows an incredibly diverse range of therapies targeting multiple signaling pathways and molecules integral to cancer development. Thi......
  • Global Biologic Therapeutics Market 2014-2018
    Published: 29-Oct-2014        Price: US $3500 Onwards        Pages: 185
    Biologic therapeutics include virus, therapeutic serum, toxin, allergenic product, antitoxin, blood component or derivative, vaccine, blood, protein (except any chemically synthesized polypeptide), or analogous product, or arsphenamine or derivative of arsphenamine (or any other trivalent organic arsenic compound), intended for the prevention, treatment, or cure of a disease or condition. These products differ from small molecules in terms of molecular weight, structure, synthesis, and immunogen......
  • Egypt Pharmaceuticals and Healthcare Report Q4 2014
    Published: 29-Oct-2014        Price: US $1295 Onwards        Pages: 126
    BMI View: Egypt's relative political stability will lead to a pickup in growth over the coming quarters, increasing the attractiveness of the pharmaceutical market - for which our forecast has been revised slightly upwards. The government's increased emphasis on developing the pharmaceutical sector and the announced expansion of the Medicare healthcare programme are positive developments this quarter. The challenges faced by pharmaceutical companies wishing to operate in the market are the c......
  • Global Pharmaceutical Packaging Market 2014-2018
    Published: 29-Oct-2014        Price: US $2500 Onwards        Pages: 77
    A pharmaceutical product is any chemical substance formulated or compounded as a single active ingredient. The packaging of medicines is a very complex process, and because of its molecular and chemical structure, it needs to be packed in an extremely durable material so that it could reach the customer in a desirable condition. The evolution of new diseases and increased health awareness have brought a transformation in the Pharmaceutical Packaging market. The vendors in the Global Pharmaceutic......
  • Indonesia Pharmaceuticals and Healthcare Report Q4 2014
    Published: 29-Oct-2014        Price: US $1295 Onwards        Pages: 142
    BMI View: Indonesia is one of the most promising markets for the pharmaceutical and healthcare companies in South East Asia. The country's large population, positive economic outlook and considerable disease burden bode well for growth in demand for drugs, medical devices and healthcare services. The ongoing implementation of the universal healthcare scheme in Indonesia coupled with the impending launch of the ASEAN Economic Community will provide growth opportunities for pharmaceutical firm......
  • Global Polymerase Chain Reaction (PCR) Market 2014-2018
    Published: 29-Oct-2014        Price: US $2500 Onwards        Pages: 75
    Polymerase Chain Reaction (PCR) is a technique of molecular genetics, which allows amplification and analysis of nucleic acid. It is very precise, specific and accurate technique used to amplify a specific DNA target from a mixture of DNA molecules. It is used in a wide array of applications in research and diagnosis, including genetic engineering, cloning, sequencing, diagnosis, genotyping, and many other areas. Advances in PCR technology and tools provide high reproducibility within a short pe......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs